XML 114 R9.htm IDEA: XBRL DOCUMENT
v3.10.0.1

4. SHAREHOLDERS' EQUITY | 9 Months Ended
--- | ---
Sep. 30, 2018
Stockholders' Equity Note [Abstract] |
SHAREHOLDERS' EQUITY | Preferred Stock On October 11, 2013, the Company filed a Certificate of Designations, Number, Voting Power, Preferences and Rights of Series C Convertible Preferred Stock (the “Certificate of Designations”), under which it designated 100,000 shares of Series C Preferred Stock, par value $10.00. The Series C Preferred Stock was entitled to accruing dividends (payable, at the Company’s options, in either cash or stock) of 5% per annum until October 10, 2016, and 3% per annum until October 10, 2018. The Series C Preferred Stock was senior to the Company’s Common Stock and any other currently issued series of the Company’s Preferred Stock upon liquidation and was entitled to a liquidation preference per share equal to the original issuance price of such shares of Series C Preferred Stock together with the amount of all accrued but unpaid dividends thereon. Each of the Series C Shares was convertible at the option of the holder into 1,000 shares of Common Stock as provided in the Certificate. Additionally, each holder of Series C Preferred Stock was entitled to vote on all matters submitted for a vote of the holders of Common Stock a number of votes equal to the number of full shares of Common Stock into which such holder’s Series C shares could have been converted. As of December 31, 2017, there were 85,561 shares of Series C Preferred Stock issued and outstanding. In February and March 2018, the Company issued 100,567,691 shares of Common Stock for the conversion of 85,561 shares of Series C Convertible Preferred Stock and $1,050,468 of related Series C dividends. Dividends were converted at $0.07 per share. As of September 30, 2018, and December 31, 2017, there were 0 and 85,561 shares of Series C Preferred Stock outstanding, respectively. Series C Preferred dividends were $28,061 and $100,677 for the nine months ended September 30, 2018 and 2017, respectively. As an inducement to encourage the Series C Preferred Stock shareholders to convert their Series C Preferred Stock to Common Stock prior to October 10, 2018, the Company offered to apply the full dividend, (accelerated to October 10, 2018) upon the shareholders exercise of their conversion. The fair value of the extra shares of Common Stock issued to Series C Stock shareholders was $103,197 for dividends that would have accrued from the date of their conversion through October 10, 2018. Common Stock On March 6, 2018, the Company issued 22,651,356 shares of Common Stock for the conversion of $1,200,000 in Related Party convertible debt and $385,594 in accrued interest. In February and March 2018, the Company issued 100,567,691 shares of Common Stock for the conversion of 85,561 shares of Series C Convertible Preferred Stock and $1,050,468 of related Series C dividends. During the three-months ended September 30, 2018, the Company issued no shares of Common Stock. Warrants A summary of the status of the warrants granted for the nine-months ended September 30, 2018, and changes during the period then ended is presented below:
|  | For the Nine-months Ended September 30, 2018 |
|  | Shares |  |  | Weighted Average Exercise Price |
Outstanding at beginning of period |  |  | 5,100,000 |  |  | $ | 0.06 |
Granted |  |  | - |  |  |  | - |
Exercised |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Expired |  |  | (5,100,000 | ) |  |  | 0.06 |
Outstanding at end of period |  |  | - |  |  | $ | - |
Stock Options A summary of the status of the stock options granted for the nine-month period ended September 30, 2018, and changes during the period then ended is presented below:
|  | For the Nine-months Ended September 30, 2018 |
|  | Options |  |  | Weighted Average Exercise Price |
Outstanding at beginning of period |  |  | 1,150,000 |  |  | $ | 0.06 |
Granted |  |  | 400,000 |  |  |  | 0.06 |
Exercised |  |  | - |  |  |  | - |
Forfeited |  |  | - |  |  |  | - |
Expired |  |  | - |  |  |  | - |
Outstanding at end of period |  |  | 1,550,000 |  |  | $ | 0.06 |
|  |  |  | As of September 30, 2018 |  |  | As of September 30, 2018 |
|  |  |  | Stock Options Outstanding |  |  |  |  |  | Stock Options Exercisable |  |  |  |
| Exercise Price |  |  | Number Outstanding |  |  | Weighted-Average Remaining Contract Life |  |  | Weighted- Average Exercise Price |  |  | Number Exercisable |  |  | Weighted-Average Exercise Price |
| $ | 0.06 |  |  |  | 1,550,000 |  |  |  | 4.38 |  |  | $ | 0.06 |  |  |  | - |  |  | $ | - |
On December 31, 2017, the Company granted a total of 1,150,000 options to five employees. The options vest in equal annual amounts over three years and the aggregate fair value of the awards was determined to be $61,322 which will be expensed over the three-year vesting period. On April 13, 2018, the Company granted a total of 200,000 options to one employee and one contractor. The options vest in equal annual amounts over three years and the aggregate fair value of the awards was determined to be $8,943 which will be expensed over the three-year vesting period. On August 31, 2018 the Company granted a total of 200,000 options to one employee. The options vest in equal annual amounts over three years and the aggregate fair value of the awards was determined to be $16,405 which will be expensed over the three-year vesting period. During the nine-month period ending September 30, 2018 an option expense of $17,278 was recognized.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration